149 related articles for article (PubMed ID: 2427828)
21. Mexiletine for control of drug-resistant ventricular tachycardia: clinical and electrophysiologic results in 44 patients.
Waspe LE; Waxman HL; Buxton AE; Josephson ME
Am J Cardiol; 1983 Apr; 51(7):1175-81. PubMed ID: 6340451
[TBL] [Abstract][Full Text] [Related]
22. Mexiletine for recurring ventricular arrhythmias: assessment by long-term electrocardiographic recordings and sequential electrophysiologic studies.
Flaker GC; Madigan NP; Alpert MA; Moser SA
Am Heart J; 1984 Sep; 108(3 Pt 1):490-5. PubMed ID: 6475711
[TBL] [Abstract][Full Text] [Related]
23. Long-term efficacy of mexiletine alone and in combination with class Ia antiarrhythmic drugs for refractory ventricular arrhythmias.
Whitford EG; McGovern B; Schoenfeld MH; Garan H; Newell JB; McElroy M; Ruskin JN
Am Heart J; 1988 Feb; 115(2):360-6. PubMed ID: 3341170
[TBL] [Abstract][Full Text] [Related]
24. Electrophysiologic effects of mexiletine on normal and ischemic ventricles.
Yoon MS; Han J
J Electrocardiol; 1982 Apr; 15(2):109-13. PubMed ID: 7069325
[TBL] [Abstract][Full Text] [Related]
25. Comparative study of mexiletine and quinidine in the treatment of ventricular ectopia.
Assey ME; Hudson WM; Hanger KH; Miller SC
South Med J; 1985 May; 78(5):565-8. PubMed ID: 2581322
[TBL] [Abstract][Full Text] [Related]
26. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
Sager PT; Nademanee K; Antimisiaris M; Pacifico A; Pruitt C; Godfrey R; Singh BN
Circulation; 1993 Sep; 88(3):1072-82. PubMed ID: 8353869
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the antiarrhythmic efficacy of disopyramide and mexiletine against stimulus-induced ventricular tachycardia.
Breithardt G; Seipel L; Abendroth RR
J Cardiovasc Pharmacol; 1981; 3(5):1026-37. PubMed ID: 6168848
[TBL] [Abstract][Full Text] [Related]
28. Quinidine/quinine: stereospecific electrophysiologic and antiarrhythmic effects in a canine model of ventricular tachycardia.
Sheldon RS; Rahmberg M; Duff HJ
J Cardiovasc Pharmacol; 1990 Nov; 16(5):818-23. PubMed ID: 1703606
[TBL] [Abstract][Full Text] [Related]
29. Oral mexiletine in the treatment of refractory ventricular arrhythmias: the role of electrophysiologic techniques.
Schoenfeld MH; Whitford E; McGovern B; Garan H; Ruskin JN
Am Heart J; 1984 May; 107(5 Pt 2):1071-8. PubMed ID: 6372423
[TBL] [Abstract][Full Text] [Related]
30. Effects of quinidine on arrhythmias and conduction in an isolated tissue model of ischemia and reperfusion.
Li GR; Ferrier GR
J Cardiovasc Pharmacol; 1991 Feb; 17(2):239-48. PubMed ID: 1709228
[TBL] [Abstract][Full Text] [Related]
31. Mexiletine in the treatment of resistant ventricular arrhythmias: enhancement of efficacy and reduction of dose-related side effects by combination with quinidine.
Duff HJ; Roden D; Primm RK; Oates JA; Woosley RL
Circulation; 1983 May; 67(5):1124-8. PubMed ID: 6831673
[No Abstract] [Full Text] [Related]
32. Mexiletine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias.
Monk JP; Brogden RN
Drugs; 1990 Sep; 40(3):374-411. PubMed ID: 2226221
[TBL] [Abstract][Full Text] [Related]
33. Mexiletine and quinidine in ventricular ectopy.
Fenster PE; Hanson CD
Clin Pharmacol Ther; 1983 Aug; 34(2):136-42. PubMed ID: 6347497
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of mexiletine in chronic ventricular arrhythmias compared with quinidine: a single-blind, randomized trial.
Singh JB; Rasul AM; Shah A; Adams E; Flessas A; Kocot SL
Am J Cardiol; 1984 Jan; 53(1):84-7. PubMed ID: 6362388
[TBL] [Abstract][Full Text] [Related]
35. Low dose quinidine-mexiletine combination therapy versus quinidine monotherapy for treatment of ventricular arrhythmias.
Giardina EG; Wechsler ME
J Am Coll Cardiol; 1990 Apr; 15(5):1138-45. PubMed ID: 2179362
[TBL] [Abstract][Full Text] [Related]
36. Electrocardiographic interactions between pinacidil, a potassium channel opener and class I antiarrhythmic agents in guinea-pig isolated perfused heart.
Yang Q; Padrini R; Bova S; Piovan D; Magnolfi G
Br J Pharmacol; 1995 Apr; 114(8):1745-9. PubMed ID: 7599944
[TBL] [Abstract][Full Text] [Related]
37. Broad antiarrhythmic effect of mexiletine in different arrhythmia models.
Frommeyer G; Garthmann J; Ellermann C; Dechering DG; Kochhäuser S; Reinke F; Köbe J; Wasmer K; Eckardt L
Europace; 2018 Aug; 20(8):1375-1381. PubMed ID: 29016765
[TBL] [Abstract][Full Text] [Related]
38. Electrophysiological actions of mexiletine on isolated rabbit atria and canine ventricular muscle and purkinje fibres.
Yamaguchi I; Singh BN; Mandel WJ
Cardiovasc Res; 1979 May; 13(5):288-96. PubMed ID: 476749
[TBL] [Abstract][Full Text] [Related]
39. Immediate quantitation of antiarrhythmic drug effect by monophasic action potential recording in coronary artery disease.
Platia EV; Weisfeldt ML; Franz MR
Am J Cardiol; 1988 Jun; 61(15):1284-7. PubMed ID: 3376887
[TBL] [Abstract][Full Text] [Related]
40. Comparative electropharmacology of mexiletine, lidocaine and quinidine in a canine Purkinje fiber model.
Burke GH; Loukides JE; Berman ND
J Pharmacol Exp Ther; 1986 Apr; 237(1):232-6. PubMed ID: 3958966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
